Transdermal Drug Delivery Systems Market 2021-2027 Trends, Research Report, Growth Trends, Opportunities, Forecast to 2027

The transdermal drug delivery systems market was valued at $6,063.85 million in 2019 and is expected to reach $8,415.04 million by 2027. It is expected to grow at a CAGR of 4% from 2021 to 2027. The prevalence of chronic diseases where existing drug delivery systems, such as oral medications, have low efficacy due to primary metabolism of the liver, is leading the market.

Key Market Players

The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), and GlaxoSmithKline (UK). Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

Transdermal Drug Delivery Systems Market Segmentations

By Type of Delivery System

Passive

• Matrix System
• Reservoir System

Active

• Structure Based
• Electrical Based
• Others

By Application

• Analgesics
• Hormone Replacement Therapy
• Cardiovascular Disorders
• Motion Sickness
• Smoking Cessation
• Others

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Key Questions Answered by Transdermal Drug Delivery Systems Market Report

• What was the Transdermal Drug Delivery Systems Market in 2020 and 2021; what are the estimated growth trends and market forecast (2021-2027).
• What will be the CAGR of Transdermal Drug Delivery Systems Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2018? How are these segments are expected to grow during the forecast period (2021-2027)?
• Which manufacturer/vendor/players in the Transdermal Drug Delivery Systems Market was the market leader in 2018?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.